Dr. Graff is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2316 E Meyer Blvd
1 Cancer West
Kansas City, MO 64132Phone+1 816-276-4700Fax+1 816-276-3810
Education & Training
- University of Kansas School of MedicineFellowship, Hematology and Medical Oncology, 2008 - 2011
- University of Missouri-Kansas City School of MedicineResidency, Internal Medicine, 2004 - 2007
- University of Missouri Kansas City School of MedicineClass of 2004
Certifications & Licensure
- RI State Medical License 2021 - 2026
- KS State Medical License 2008 - 2021
- MO State Medical License 2006 - 2021
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
Publications & Presentations
PubMed
- Locoregional event or dyssynchronous distant metastasis: clinicopathological and molecular analysis of contralateral axillary lymph node metastasis in breast cancer pa...Yihong Wang, Liu Liu, Stephanie L Graff, Liang Cheng
Histopathology. 2025-02-01 - "Nailing down" risk and improving outcomes in early-stage breast cancer.Stephanie L Graff, Stacey Tinianov, Kevin Kalinsky
Journal of the National Cancer Institute. 2025-02-01 - TRAIL agonists rescue mice from radiation-induced lung, skin or esophageal injury.Jillian Strandberg, Anna Louie, Seulki Lee, Marina Hahn, Praveen Srinivasan
The Journal of Clinical Investigation. 2025-01-14
Press Mentions
- ‘Clinically Meaningful’ Outcomes in Cancer Care Extend Beyond SurvivalFebruary 3rd, 2025
- The Oncology Brothers Advancements in Oncology: What Community Oncologists Can Bring to Their Practice of Breast CancerJanuary 7th, 2025
- Muddier Waters and an FDA Approval? Phase 3 Imlunestrant Data May Shake Up Breast Cancer CareJanuary 3rd, 2025
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: